Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03333746 · TERMINATED
Trial details
- NCT number
- NCT03333746
- Sponsor
- Yvonne Efebera
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2018-08-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.